1. Home
  2. Live Updates
  3. Anish bhatnagar

Live Breaking News & Updates on Anish bhatnagar

Stay informed with the latest breaking news from Anish bhatnagar on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Anish bhatnagar and stay connected to the pulse of your community

Diazoxide Chloride Designated Breakthrough Therapy for Prader-Willi Syndrome

The investigational product is an extended-release tablet formulation of diazoxide chloride, the crystalline salt of diazoxide.

Anish-bhatnagar , Drug-administration , Breakthrough-therapy , Fast-track ,

Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)

Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Brian-ritchie , Anish-bhatnagar , Soleno-therapeutics-inc , Foundation-for-prader-willi-research , Drug-administration , Lifesci-advisors , Prader-willi-syndrome-association-united-states , Securities-exchange , Diazoxide-choline , Extended-release-tablets , Prader-willi-syndrome

Soleno Therapeutics (SLNO) Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

Soleno Therapeutics (SLNO) Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Anish-bhatnagar , Drug-administration , Soleno-therapeutics-inc , Soleno-therapeutics , Breakthrough-therapy-designation , Chief-executive-officer , Therapy-designation , With-breakthrough-therapy-designation , Orphan-drug-designation , Fast-track-designation ,

Soleno Therapeutics Receives Breakthrough Therapy

First Ever Breakthrough Designation for a Drug Being Developed for PWS Designation is Based on Data from the Phase 3 Program for DCCR Planned...

United-states , Brian-ritchie , Anish-bhatnagar , Foundation-for-prader-willi-research , Drug-administration , Lifesci-advisors , Prader-willi-syndrome-association-united-states , Securities-exchange , Soleno-therapeutics-inc , First-ever-breakthrough-designation , Drug-being-developed , New-drug-application

Soleno Therapeutics to Present at Upcoming February Investor Conferences

01.02.2024 - REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) - Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish ...

Anish-bhatnagar , Soleno-therapeutics-inc , Chief-executive-officer , Healthcare-talks ,

Billionaire Seth Klarman's Biotech Stock Picks

In this article, we discuss billionaire Seth Klarman’s biotech stock picks.

New-york , United-states , Cayman-islands , Boston , Massachusetts , California , China , Cornell-university , American , Michael-price , Andrew-weis-weiss , Seth-klarman

Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Long-Term Open-Label Study of DCCR in Prader-Willi Syndrome

Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Long-Term Open-Label Study of DCCR in Prader-Willi Syndrome
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Brian-ritchie , Anish-bhatnagar , Foundation-for-prader-willi-research , Lifesci-advisors , Drug-administration , Soleno-therapeutics-inc , Securities-exchange , Prader-willi-syndrome-association-united-states , Therapeutics-announces-peer-reviewed-publication , Long-term-open-label-study , Diazoxide-choline

PWS children who switch from DCCR see worsening hyperphagia: Trial -October 06, 2023 at 11:48 am EDT

Soleno to file FDA application by mid-2024 to request treatment's approval


Prader-Willi syndrome patients who switched from daily treatment with DCCR to a placebo experienced...

Anish-bhatnagar , Drug-administration , European-union , Soleno-therapeutics , Prader-willi-syndrome , Markets ,

SLNO Stock: Meet Soleno, The Company Whose Hunger Suppressant Sent Shares Skyrocketing 505%

SLNO Stock: Meet Soleno, The Company Whose Hunger Suppressant Sent Shares Skyrocketing 505%
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Anish-bhatnagar , Prader-willi , Drug-administration , Soleno-therapeutics , Chief-executive-anish-bhatnagar , Novo-nordisk , Eli-lilly , Relative-strength-rating , Composite-rating ,

Meet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505%

Soleno came out from "under the radar" in a big way, CEO Anish Bhatnagar said after SLNO stock more than sextupled in a single day. The post Meet Soleno…

Anish-bhatnagar , Company-whose-hunger-suppressant-sent-shares , Meet-soleno-therapeutics , News , Ggregator , Reaking-news , Uration , Edia ,